Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis

Abstract Although most patients recover from COVID-19, it has been linked to cardiac, pulmonary, and neurologic complications. Despite not having formal criteria for its diagnosis, COVID-19 associated cardiomyopathy has been observed in several studies through biomarkers and imaging. This study aims...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Louie F. Dy, Ryan C. V. Lintao, Cynthia P. Cordero, Ian Theodore G. Cabaluna, Leonila F. Dans
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/a09e4a925dc5400da39f4cdaa97f712e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a09e4a925dc5400da39f4cdaa97f712e
record_format	dspace
spelling	oai:doaj.org-article:a09e4a925dc5400da39f4cdaa97f712e2021-12-02T17:32:56ZPrevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis10.1038/s41598-021-87961-x2045-2322https://doaj.org/article/a09e4a925dc5400da39f4cdaa97f712e2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87961-xhttps://doaj.org/toc/2045-2322Abstract Although most patients recover from COVID-19, it has been linked to cardiac, pulmonary, and neurologic complications. Despite not having formal criteria for its diagnosis, COVID-19 associated cardiomyopathy has been observed in several studies through biomarkers and imaging. This study aims to estimate the proportion of COVID-19 patients with cardiac abnormalities and to determine the association between the cardiac abnormalities in COVID-19 patients and disease severity and mortality. Observational studies published from December 1, 2019 to September 30, 2020 were obtained from electronic databases (PubMed, Embase, Cochrane Library, CNKI) and preprint servers (medRxiv, bioRxiv, ChinaXiv). Studies that have data on prevalence were included in the calculation of the pooled prevalence, while studies with comparison group were included in the calculation of the odds ratio. If multiple tests were done in the same study yielding different prevalence values, the largest one was used as the measure of prevalence of that particular study. Metafor using R software package version 4.0.2 was used for the meta-analysis. A total of 400 records were retrieved from database search, with 24 articles included in the final analysis. Pooled prevalence of cardiac abnormalities in 20 studies was calculated to be 0.31 [95% Confidence Intervals (CI) of (0.23; 0.41)], with statistically significant heterogeneity (percentage of variation or I-squared statistic I2 = 97%, p < 0.01). Pooled analysis of 19 studies showed an overall odds ratio (OR) of 6.87 [95%-CI (3.92; 12.05)] for cardiac abnormalities associated with disease severity and mortality, with statistically significant heterogeneity (I2 = 85%, between-study variance or tau-squared statistic τ2 = 1.1485, p < 0.01). Due to the high uncertainty in the pooled prevalence of cardiac abnormalities and the unquantifiable magnitude of risk (although an increased risk is certain) for severity or mortality among COVID-19 patients, much more long-term prognostic studies are needed to check for the long-term complications of COVID-19 and formalize definitive criteria of “COVID-19 associated cardiomyopathy”.Louie F. DyRyan C. V. LintaoCynthia P. CorderoIan Theodore G. CabalunaLeonila F. DansNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Louie F. Dy Ryan C. V. Lintao Cynthia P. Cordero Ian Theodore G. Cabaluna Leonila F. Dans Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
description	Abstract Although most patients recover from COVID-19, it has been linked to cardiac, pulmonary, and neurologic complications. Despite not having formal criteria for its diagnosis, COVID-19 associated cardiomyopathy has been observed in several studies through biomarkers and imaging. This study aims to estimate the proportion of COVID-19 patients with cardiac abnormalities and to determine the association between the cardiac abnormalities in COVID-19 patients and disease severity and mortality. Observational studies published from December 1, 2019 to September 30, 2020 were obtained from electronic databases (PubMed, Embase, Cochrane Library, CNKI) and preprint servers (medRxiv, bioRxiv, ChinaXiv). Studies that have data on prevalence were included in the calculation of the pooled prevalence, while studies with comparison group were included in the calculation of the odds ratio. If multiple tests were done in the same study yielding different prevalence values, the largest one was used as the measure of prevalence of that particular study. Metafor using R software package version 4.0.2 was used for the meta-analysis. A total of 400 records were retrieved from database search, with 24 articles included in the final analysis. Pooled prevalence of cardiac abnormalities in 20 studies was calculated to be 0.31 [95% Confidence Intervals (CI) of (0.23; 0.41)], with statistically significant heterogeneity (percentage of variation or I-squared statistic I2 = 97%, p < 0.01). Pooled analysis of 19 studies showed an overall odds ratio (OR) of 6.87 [95%-CI (3.92; 12.05)] for cardiac abnormalities associated with disease severity and mortality, with statistically significant heterogeneity (I2 = 85%, between-study variance or tau-squared statistic τ2 = 1.1485, p < 0.01). Due to the high uncertainty in the pooled prevalence of cardiac abnormalities and the unquantifiable magnitude of risk (although an increased risk is certain) for severity or mortality among COVID-19 patients, much more long-term prognostic studies are needed to check for the long-term complications of COVID-19 and formalize definitive criteria of “COVID-19 associated cardiomyopathy”.
format	article
author	Louie F. Dy Ryan C. V. Lintao Cynthia P. Cordero Ian Theodore G. Cabaluna Leonila F. Dans
author_facet	Louie F. Dy Ryan C. V. Lintao Cynthia P. Cordero Ian Theodore G. Cabaluna Leonila F. Dans
author_sort	Louie F. Dy
title	Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
title_short	Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
title_full	Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
title_fullStr	Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
title_full_unstemmed	Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis
title_sort	prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with covid-19: a systematic review and meta-analysis
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/a09e4a925dc5400da39f4cdaa97f712e
work_keys_str_mv	AT louiefdy prevalenceandprognosticassociationsofcardiacabnormalitiesamonghospitalizedpatientswithcovid19asystematicreviewandmetaanalysis AT ryancvlintao prevalenceandprognosticassociationsofcardiacabnormalitiesamonghospitalizedpatientswithcovid19asystematicreviewandmetaanalysis AT cynthiapcordero prevalenceandprognosticassociationsofcardiacabnormalitiesamonghospitalizedpatientswithcovid19asystematicreviewandmetaanalysis AT iantheodoregcabaluna prevalenceandprognosticassociationsofcardiacabnormalitiesamonghospitalizedpatientswithcovid19asystematicreviewandmetaanalysis AT leonilafdans prevalenceandprognosticassociationsofcardiacabnormalitiesamonghospitalizedpatientswithcovid19asystematicreviewandmetaanalysis
_version_	1718380138935091200

Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis

Ejemplares similares